IL-36γ was shown to strengthen the effector functions of CD8+T cells, NK cells, and γδ T cells, making the tumor microenvironment favor tumor destruction, and ultimately to have profound anti-tumor effects, suppressing both tumor growth and metastasis (74). This evidence concerns the gene CD8A and neoplasm.